Atossa Therapeutics, Inc. (ATOS)

Price & Market Data

Price: $4.97

Daily Change: -$0.0049 / 0.10%

Daily Range: $4.84 - $5.10

Market Cap: $42,712,688

Daily Volume: 28,153

Performance Metrics

1 Week: -2.35%

1 Month: -14.99%

3 Months: 13.93%

6 Months: -55.84%

1 Year: -61.81%

YTD: -43.86%

About Atossa Therapeutics, Inc. (ATOS)

Get the latest market data on Atossa Therapeutics, Inc. (ATOS). Price: 4.97, daily change: -$0.0049 / 0.10%. Market cap: 42,712,688. Comprehensive performance from 3-month to 1-year.

Company Details

Employees: 14

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.

Selected stocks

New Fortress Energy Inc. (NFE)

Microvast Holdings, Inc. (MVST)

Loop Industries, Inc. (LOOP)

Elme Communities (ELME)

Evaxion A/S (EVAX)